Aclaris Therapeutics, Inc. | 8,695 followers on LinkedIn. Aclaris is committed to developing innovative therapies to address the needs of people with immuno-inflammatory diseases | Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.